Clinical trial Recruiting at 1 site Interventional Ages 18 and up

VR avatar therapy for psychosis: linking thinking, self-awareness, and social cognition

Official title: Evaluation of Cognitive, Metacognitive, Social Cognition and Trauma Related-Variables in Patients With Psychosis Receiving VR-Based Avatar Therapy

Run by Fundació Sant Joan de Déu · NCT07091344 · Data updated 2026-11-12

This project will test whether cognitive, metacognitive, and social-cognition factors relate to how well VR-based avatar therapy helps people with schizophrenia who have persistent auditory hallucinations.

More Schizophrenia Disorders trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorFundació Sant Joan de Déu
Academic / other
Locations1 site (Barcelona, Catalonia)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedSeptember 30, 2026
Study endsDecember 30, 2026
Registry record updatedAugust 29, 2025
Trial IDNCT07091344 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a DSM-5 schizophrenia-spectrum diagnosis, persistent auditory hallucinations despite treatment, stable medication for at least four weeks, fluent in Spanish, and able to attend in-person VR sessions are ideal candidates.

Probably not a fit

People who cannot tolerate VR, have severe visual or neurological impairments, active substance abuse, intellectual disability, current suicidal risk, or who cannot identify a dominant voice for the avatar may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with schizophrenia and ongoing auditory hallucinations will receive seven individual VR-based avatar therapy sessions delivered over a 12-week intervention period. Researchers will measure neurocognition, metacognition, emotion recognition, attributional style, theory of mind, and social perception using validated tools at screening, baseline, during therapy, and at a post-therapy follow-up. Childhood trauma will also be measured to explore its role as a predisposing factor. The goal is to identify which cognitive and metacognitive profiles predict better or worse therapy outcomes to inform more personalized approaches.

Why it matters

Potential benefit: If successful, the study could help tailor VR avatar therapy to individuals by identifying cognitive or metacognitive traits linked to better outcomes.

How similar studies have gone: Previous avatar-based VR interventions for auditory hallucinations have shown promising results, but combining them with detailed cognitive and metacognitive profiling is a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\*

* Adults aged 18 years or older.
* Diagnosis of schizophrenia spectrum disorder according to DSM-5 criteria.
* Experience of persistent auditory hallucinations for at least 3 months (PANSS hallucination score ≥ 3).
* Stable medication dosage for at least 4 weeks prior to recruitment.
* Fluent in the spoken language of the study site (Spanish).
* Able to provide informed consent.
* Regular psychiatric follow-up care.

\*\*Exclusion Criteria:\*\*

* Inability to identify a dominant voice for Avatar Therapy intervention.
* Intellectual disability based on medical history.
* Active substance abuse.
* Central nervous system injury or neurological disorders affecting cognitive performance.
* Severe visual impairment that precludes the use of VR technology.
* Aversion to virtual reality or prior experience of simulator sickness.
* Current suicidal ideation or risk.
* Lack of cooperation or inability to comply with study procedures.

Where it's running

  • Fundació Sant Joan de Déu - Unitat de Recerca del Parc Sanitari Sant Joan de Déu
    Barcelona, Catalonia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.